• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Editor's Choice

Precision metagenomics: a rapid solution for identifying and characterizing microbial agents of infectious disease.

October 17, 2024 Microbiome Times

Next-generation sequencing (NGS) represents an innovative and versatile technology for microbial identification and characterization. NGS offers flexibility to scale methods based on the experimental interest. Widely available NGS methods include amplicon sequencing, hybrid capture, whole-genome […]

Pharma & Human Health

Sequential Launches Industry-First Microbiome Target Panels for Skin Conditions

October 16, 2024 Microbiome Times

Sequential is excited to announce the launch of the industry’s first-ever Targeted Skin Condition Panels through the lens of the Microbiome, designed to address major skin concerns such as acne, rosacea, atopic dermatitis, malodor, and […]

Pharma & Human Health

A potential non-invasive stool test and novel therapy for endometriosis

October 16, 2024 Microbiome Times

Promising findings by researchers at Baylor College of Medicine and collaborating institutions could lead to the development of a non-invasive stool test and a new therapy for endometriosis, a painful condition that affects nearly 200 million women […]

Editor's Choice

Exhaling Clues to the Activity of the Microbiome with Owlstone’s Breath Biopsy Technology – An Interview with Dr. Liz Crone

October 15, 2024 Microbiome Times

Have you considered analyzing captured breath to uncover the secrets of microbial metabolism? In this interview, we speak to Dr Liz Crone, Head of Business Development, Research Products & Services for Europe and Asia at breath-based […]

Finance

Lesaffre acquires Altar, an Adaptive Laboratory Evolution start-up from Ginkgo Bioworks

October 7, 2024 Microbiome Times

Lesaffre, a key global player in the field of fermentation and microorganisms, announces the acquisition of Altar, a French start-up specializing in Adaptive Laboratory Evolution (ALE). Created in 2017, Altar will complement Lesaffre’s existing know-how […]

Finance

dsm-firmenich completes the sale of yeast extract business to Lesaffre

October 2, 2024 Microbiome Times

dsm-firmenich, innovators in nutrition, health and beauty, today announces the completion of the sale of its yeast extract business to Lesaffre, a global player in fermentation and microorganisms. The sale of the yeast extract business […]

Finance

Ostia Sciences Inc. Secures Seed Investment, Finalizes IP and Prepares Microbiome Technology Prototype 

October 2, 2024 Microbiome Times

Ostia Sciences Inc., a spinout from the University of Toronto specializing in oral and respiratory microbiome solutions, has successfully raised over CAD $1 million in its seed round and secured full intellectual property (IP) transfer […]

Finance

Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use

October 1, 2024 Microbiome Times

 Florey Biosciences, a synthetic biology company spun out of the Wyss Institute for Biologically Inspired Engineering at Harvard University, today announced that it has secured pre-seed funding and is unveiling its lead program, a probiotic […]

Pharma & Human Health

EUDRACAP® colon functional capsules for ileo-colonic delivery: Formulating the next generation of live biotherapeutic products

October 1, 2024 Bettina Hoelzer and Lucas Cusin

Advances in live biotherapeutic products and key formulation challenges Live Biotherapeutic Products (LBPs) are living bacterial drugs that can be used to prevent or treat certain human diseases. This rising class of pharmaceutical drugs is […]

Editor's Choice

EMIH and MTIG join forces with Microbiome Times on important deal-making event, taking place Brussels 2025

September 25, 2024 Microbiome Times

Microbiome Times Magazine, the microbiome industry’s leading B2B publication, is pleased to announce its collaboration with the coalition groups European Microbiome Innovation for Health (EMIH) and Microbiome Therapeutics Innovation Group (MTIG) for its upcoming Microbiome […]

Pharma & Human Health

Next-Generation Sequencing for Microbial Community Profiling

September 25, 2024 Microbiome Times

On-Demand Webinar Learn about utilizing next-generation sequencing (NGS) to analyze the genetic diversity and function of complex microbial communities. Compared to culture-based methods, powerful techniques like metagenomics and metatranscriptomics can provide a more comprehensive and […]

Posts navigation

« 1 … 6 7 8 … 84 »

Sign Up to Free Newsletter

Editor’s Choice

  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
sign up

Sign up to the Microbiome Times newsletter